[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BiopharmIQ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::811036897883492352.png) BiopharmIQ by Amp [@BiopharmIQ](/creator/twitter/BiopharmIQ) on x 25.7K followers
Created: 2025-07-15 23:06:21 UTC

$ARCT
ARCT-032 / Cystic Fibrosis / Phase X

» Safety findings
→ No SAEs, severe AEs, or dose-limiting toxicities
→ Dose-related increase in transient, mild, post-dose respiratory symptoms

» PK findings: Very low systemic exposure
→ mRNA: all plasma specimens BLQ
→ LNP lipid components sporadically detected in low concentrations (<1.0 ng/mL)

Prior results & Ph2 trial overview 📸 👇

2/7

![](https://pbs.twimg.com/media/Gv7rDAgXkAAULwn.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945258666174898389/c:line.svg)

**Related Topics**
[arct](/topic/arct)
[plasma](/topic/plasma)
[transient](/topic/transient)
[$arct](/topic/$arct)

[Post Link](https://x.com/BiopharmIQ/status/1945258666174898389)